Skip to content

Price / book at other companies

Eli Lilly logo
Eli LillyLLY
26.3×-20.7×
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
3.4×+1.6×
Opko Health logo
Opko HealthOPK
0.7×-0.1×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
4.9×+3.8×
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
143.7×+142×
Erasca, Inc. logo
Erasca, Inc.ERAS
12.8×+11.8×

Other financials

Income statement

See full
Operating income-$58.0M-66.3%
Net income-$53.1M-74.7%
EPS (diluted)-$0.52-44.4%

Balance sheet

See full
Cash & equivalents$52.5M+3.8%
Total debt$956.0K-16.7%
Total equity$480.5M+25.3%
Total assets$530.6M+29.5%

Cash flow

See full
Operating cash flow-$46.0M-4.6%
CapEx-
Free cash flow-$34.5M-27.8%

Valuation

See full
Market cap$973.05M+244%
Enterprise value$921.46M+295%

Returns & leverage

See full
Return on equity-42.9%+1.3pp
Debt / equity0.0×
Current ratio10.9×-4.3×

Where this comes from

Calculated from Olema Pharmaceuticals, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Olema Pharmaceuticals, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Olema Pharmaceuticals, Inc.'s price / book?
Olema Pharmaceuticals, Inc. (OLMA) reported price / book of 2.7× in Q1 2026.
How has Olema Pharmaceuticals, Inc.'s price / book changed year-over-year?
Olema Pharmaceuticals, Inc.'s price / book increased by 303.6% year-over-year, from 0.7× to 2.7×.
What is the long-term trend for Olema Pharmaceuticals, Inc.'s price / book?
Over 5 years (2020 to 2025), Olema Pharmaceuticals, Inc.'s price / book has grown at a -5.6% compound annual growth rate (CAGR), from 5.6× to 4.2×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.